You are viewing an incomplete version of our website. Please click to reload the website as full version.

CHMP3 antibody (Charged Multivesicular Body Protein 3) (N-Term)

Details for Product anti-CHMP3 Antibody No. ABIN350227, Supplier: Log in to see
Antigen
  • 25.1
  • 4921505F14Rik
  • 9130011K15Rik
  • CG9779
  • CGI-49
  • CHMP3
  • D6Ertd286e
  • Dmel\\CG9779
  • dvps24
  • GB15107
  • NEDF
  • VPS24
  • Vps24
  • vps24
  • wu:fb47g01
  • zgc:76972
Epitope
N-Term
8
2
1
Reactivity
Mouse (Murine), Rat (Rattus), Human
18
8
8
2
1
1
1
Host
Sheep
16
2
Clonality
Polyclonal
Application
Immunohistochemistry (IHC), Western Blotting (WB)
17
9
8
4
2
1
Supplier
Log in to see
Supplier Product No.
Log in to see
Request

Get this product for free

It's quick and easy to submit your validation proposal. I want to validate this product

Learn more

Immunogen A synthetic peptide from the n-terminal of human CHMP3 conjugated to an immunogenic carrier protein was used as the antigen. The antigen is homologous in rat and mouse.
Specificity Specific for CHMP3.
Purification Whole serum
Alternative Name CHMP3 (CHMP3 Antibody Abstract)
Background Function: Component of the ESCRT-III complex, which is required for multivesicular bodies (MVBs) formation and sorting of endosomal cargo proteins into MVBs. The MVB pathway mediates delivery oftransmembrane proteins into the lumen of the lysosome for degradation. The ESCRT-III complex is probably involved in the concentration of MVB cargo. Required for sorting/trafficking of EGF receptor. In case of infection, the HIV-1 virus takes advantage of the ESCRT-III complex for budding and exocytic cargos of viral proteins.
Subcellular location: Cytoplasm, cytosol. Membrane, Lipid-anchor.
Tissue specificity: Widely expressed. Expressed in heart, brain, placenta, lung, liver, skeletal muscle, kidney and pancreas. Also known as: Chromatin-modifying protein 3, Vacuolar protein-sorting-associated protein 24, hVps24, Neuroendocrine differentiation factor, Charged multivesicular body protein 3, VPS24, NEDF.
Application Notes A dilution of 1 : 300 to 1 : 2000 is recommended.
The optimal dilution should be determined by the end user. Not tested in other applications.
Restrictions For Research Use only
Format Lyophilized
Reconstitution Reconstitute in 100 µL of sterile water. Centrifuge to remove any insoluble material.
Handling Advice Avoid freeze and thaw cycles.
Storage 4 °C/-20 °C
Storage Comment Maintain the lyophilised/reconstituted antibodies frozen at -20°C for long term storage and refrigerated at 2-8°C for a shorter term. When reconstituting, glycerol (1:1) may be added for an additional stability. Avoid freeze and thaw cycles.
Expiry Date 12 months
Background publications Dephoure, Zhou, Villén, Beausoleil, Bakalarski, Elledge, Gygi: "A quantitative atlas of mitotic phosphorylation." in: Proceedings of the National Academy of Sciences of the United States of America, Vol. 105, Issue 31, pp. 10762-7, 2008 (PubMed).

Hillier, Graves, Fulton, Fulton, Pepin, Minx, Wagner-McPherson, Layman, Wylie, Sekhon, Becker, Fewell, Delehaunty, Miner, Nash, Kremitzki, Oddy, Du, Sun, Bradshaw-Cordum, Ali, Carter, Cordes, Harris et al.: "Generation and annotation of the DNA sequences of human chromosomes 2 and 4. ..." in: Nature, Vol. 434, Issue 7034, pp. 724-31, 2005 (PubMed).

Strack, Calistri, Craig, Popova, Göttlinger: "AIP1/ALIX is a binding partner for HIV-1 p6 and EIAV p9 functioning in virus budding." in: Cell, Vol. 114, Issue 6, pp. 689-99, 2003 (PubMed).

von Schwedler, Stuchell, Müller, Ward, Chung, Morita, Wang, Davis, He, Cimbora, Scott, Kräusslich, Kaplan, Morham, Sundquist: "The protein network of HIV budding." in: Cell, Vol. 114, Issue 6, pp. 701-13, 2003 (PubMed).

Wilson, Oh, Hwa, Rosenfeld: "Interaction of IGF-binding protein-related protein 1 with a novel protein, neuroendocrine differentiation factor, results in neuroendocrine differentiation of prostate cancer cells." in: The Journal of clinical endocrinology and metabolism, Vol. 86, Issue 9, pp. 4504-11, 2001 (PubMed).